The assessment of musculoskeletal pain in the clinical setting (original) (raw)
Related papers
Refinement and validation of a tool for stratifying patients with musculoskeletal pain
European Journal of Pain, 2021
BackgroundPatients with musculoskeletal pain in different body sites share common prognostic factors. Using prognosis to stratify and treatment match can be clinically and cost‐effective. We aimed to refine and validate the Keele STarT MSK Tool for prognostic stratification of musculoskeletal pain patients.MethodsTool refinement and validity was tested in a prospective cohort study, and external validity examined in a pilot cluster randomized controlled trial (RCT). Study population comprised 2,414 adults visiting U.K. primary care with back, neck, knee, shoulder or multisite pain returning postal questionnaires (cohort: 1,890 [40% response]; trial: 524). Cohort baseline questionnaires included a draft tool plus refinement items. Trial baseline questionnaires included the Keele STarT MSK Tool. Physical health (SF‐36 Physical Component Score [PCS]) and pain intensity were assessed at 2‐ and 6‐month cohort follow‐up; pain intensity was measured at 6‐month trial follow‐up.ResultsThe to...
Acta Medica Transilvanica
The first and most important step in pain management is to correctly assess it. Short-form McGill Pain Questionnaire-2(SF-MPQ-2) and Multidimensional Pain Evaluation Scale (MPES) are valid and reliable tools used in clinical practice and research. Our aim was to evaluate the efficacy of pharmacological and non-pharmacological treatments applied for pain relief. 27 patients were included in the study, of which 12 were outpatients and 15 were inpatients. Statistical and clinical significant differences were obtained only for the inpatient group on the MPES (p=0.00, difference between means=3.07) and for 3 out of 4 domains of the SF-MPQ-2 (p=0.01, 0.01 and 0.00 and the difference between means=2.60, 2.00 and 2.20 for continuous pain, neuropathic pain and affective descriptors, respectively). Outcomes of pain management are better for inpatients due to a combination of analgesic drugs with physical medicine and rehabilitation procedures and a strict monitoring during their hospitalization.
PubMed, 2020
Background: The Brief Pain Inventory-Short Form (BPI-SF) and Revised Short-Form McGill Pain Questionnaire Version-2 (SF-MPQ-2) are generic pain assessment tools used in research and practice for pain assessment in musculoskeletal (MSK) conditions. A comprehensive review that systematically analyses their measurement properties in MSK conditions has not been performed. This review protocol describes the steps that will be taken to locate, critically appraise, compare and summarize clinical measurement research on the BPI-SF and SF-MPQ-2 in pain-related MSK conditions. Methods: Medline, EMBASE, CINAHL and Scopus will be searched for publications that examine the measurement properties of the Brief Pain Inventory and Revised Short-Form McGill Pain Questionnaire Version-2. Two reviewers will independently screen citations (title, abstract and full text) and extract relevant data. The extensiveness, rigor, and quality of measurement property reports will be examined with a structured measurement studies appraisal tool, and with the updated COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. Findings will be descriptively summarized, and when possible, a meta-analysis will be performed. Discussion: This review will summarize and compare the current level of evidence on the measurement properties of the BPI-SF and SF-MPQ-2 in a spectrum of musculoskeletal conditions. We expect clinicians/researchers dealing with MSK conditions to have synthesized evidence that informs their decision making and preferences. In addition, the review hopes to identify gaps and determine priorities for future research with or on the BPI-SF and SF-MPQ-2 in MSK conditions.